Abstract
Nephropathic cystinosis is a recessively inherited inborn error of metabolism characterized by greatly elevated levels of intracellular, intralysosomal cystine accumulation in many cells of affected individuals. Death from progressive renal failure usually occurs before 12 years of age, unless renal transplantation is performed (Schneider and Schulman 1983). Experimental therapy with orally administered cysteamine appears to be of some value in retardating or preventing the progress of renal damage in some patients, but treatment of this disorder is still quite unsatisfactory (Schneider et al. in preparation).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
